Aspen’s 20-percent stock decline costs South African tycoon Stephen Saad nearly $160 million
Saad's wealth drops by nearly $160 million after Aspen Pharmacare's shares tumble 20.17 percent over the past 25 days on the JSE.
Related
Koos Bekker-linked family trust offloads $162 million in Prosus stock
This highlights Bekker’s approach to blending technology investments with high-end real estate, showcasing his commitment to diversified growth.
South African billionaire Ivan Glasenberg loses $1.9 billion on Glencore stake
Glencore's share price slump wipes out $1.9 billion from Ivan Glasenberg's stake.
Clicks Group, led by Bertina Engelbrecht, attracts $31.5 million JP Morgan bet
The financial giant acquired additional shares worth $31.48 million, increasing its stake by 0.56 percentage points to 5.96 percent.
Bakhresa invests $8.4 million to expand juice production capacity
Tanzania’s Bakhresa Group doubles down on fruit juice production, boosting agriculture and exports.
Latest
Suresh Bhagwanji Shah’s stake in I&M Group gains $23 million year-to-date
This strategic move brings together two powerhouse entities and marks a significant step toward consolidating Black-led financial influence.
Jay-Z’s Marcy Ventures joins forces with Pendulum Holdings' investment arm
This strategic move brings together two powerhouse entities and marks a significant step toward consolidating Black-led financial influence.
Koos Bekker-linked family trust offloads $162 million in Prosus stock
This highlights Bekker’s approach to blending technology investments with high-end real estate, showcasing his commitment to diversified growth.
Aradel-backed consortium gets approval for $2.4 billion Shell deal
The transaction has been designed to preserve SPDC’s operational integrity post-acquisition.